Douglas Kerr
CIK 1814189 · Head of R&D and CMO · last filed 2026-10-22
Douglas Kerr is a Head of R&D and CMO who has filed 38 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for DYN, was dated Nov 13, 2026. Across all open-market trades the lifetime net is −$1.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions. 8 Form 144 notices of planned sales are also on file; the latest, for DYN on Nov 13, 2026, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
GBIO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
301 BINNEY STREET, SUITE 401
CAMBRIDGE, MA 02142
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DYN | Head of R&D and CMO | 170,564 | $16.04 | $2.74M | -$325.8K | 14 | 2026-10-22 |
| Generation Bio Co. (GBIO) Delisted | CHIEF MEDICAL OFFICER | 38,563 | $5.34 | $205.9K | -$1.55M | 16 | 2024-01-31 |
Recent Filings
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-11-13 | DYN | Notice (144) Officer · Planned Nov 13, 2026 No sale on file yet |
−2,604 | -$43.8K | EDGAR |
| 2026-10-22 | DYN | Grant (A) | +8,000 | $0 | EDGAR |
| 2026-09-08 | DYN | Notice (144) Officer · Planned Sep 8, 2026 Sold: Form 4 filed Sep 8, 2026 |
−35 | -$661 | EDGAR |
| 2026-09-08 | DYN | Sell (S)10b5-1 Plan adopted Dec 4, 2024 |
−5,035 | -$115.5K | EDGAR |
| 2026-09-04 | DYN | Notice (144) Officer · Planned Sep 4, 2026 Sold: Form 4 filed Sep 8, 2026 |
−5,000 | -$121.7K | EDGAR |
| 2026-08-17 | DYN | Sell (S)10b5-1 Plan adopted Feb 12, 2026 |
−1,556 | -$40.9K | EDGAR |
| 2026-08-13 | DYN | Notice (144) Officer · Planned Aug 13, 2026 Sold: Form 4 filed Aug 17, 2026 |
−2,443 | -$64.2K | EDGAR |
| 2026-06-17 | DYN | Sell (S)10b5-1 Plan adopted Dec 4, 2024 |
−887 | -$16.3K | EDGAR |
| 2026-05-14 | DYN | Sell (S)10b5-1 Plan adopted Feb 12, 2026 |
−1,564 | -$28.7K | EDGAR |
| 2026-03-06 | DYN | Sell (S)10b5-1 Plan adopted Dec 4, 2024 |
−904 | -$13.5K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).